Advertisement Eisai to launch Nabolin Felbinac 70 analgesic patch - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Eisai to launch Nabolin Felbinac 70 analgesic patch

Eisai has announced that it will launch a high-dose felbinac-containing anti-inflammatory analgesic patch, Nabolin Felbinac 70, for shoulder pain associated with shoulder stiffness and low back pain on March 3, 2009.

Each patch of Nabolin Felbinac 70 contains 70mg of felbinac, which is the highest dose as felbinac among non-prescription anti-inflammatory analgesic patches, to control pain or suppress inflammation, the company said.

With its large size (10cm x 14cm) that can be applied to extensive affected area with pain and its stretchy and breathable material, Nabolin Felbinac 70 provides pain relief from severe stiff shoulder and supports active day-to-day life, the company added.